A major biomedical breakthrough published in Nature Communications has unveiled a hidden driver behind metabolic disorders. Researchers from the Pennington Biomedical Research Center discovered that a buildup of a little-known muscle protein called Miro1 directly induces insulin resistance in human skeletal tissue. Preclinical experiments demonstrated that removing this protein completely restores muscle responsiveness to insulin. Interestingly, human trials within the same study revealed that structured aerobic exercise naturally lowers Miro1 levels, opening an entirely new therapeutic pathway for preventing and treating Type 2 diabetes without relying solely on heavy pharmaceutical intervention.
About the Author
